Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: A nested case-control study

Stroke

Volumn 30, Issue 12, 1999, Pages 2541-2546

  Ahmed, Ejaz ^a   Trifunovic, Jasmina ^a   Stegmayr, Birgitta ^b   Hallmans, Göran ^b   Lefvert, Ann Kari ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoantibodies; Cerebrovascular disorders; Epidemiology; Lipoproteins, LDL; Oxidants

Indexed keywords

AUTOANTIBODY; COPPER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZING AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; STROKE; WORLD HEALTH ORGANIZATION;

EID: 0032709478     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.12.2541     Document Type: Article

References (36)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Ross R. New sights into the mechanisms of atherosclerosis. In: Jacotot B, Mathe D, Fruchart JC, eds. Atherosclerosis XI. Singapore: Elsevier Science Publishing Co Inc; 1998:201-204.
3. Steinberg D, Parathasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low density lipoprotein that increase its atherogenicity. N Eng J Med. 1989;320:915-924.
4. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
5. Salonen JT, Nyyssönen K, Salonen R, Porkkala-Saratoho E, Tuomainen T-P, Diczfaiusy U, Björkhem I. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation. 1997;95:840-845.
6. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994; 344:793-795.
7. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 1990;10:325-335.
8. Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-390.
9. Ylä-Herttuala S, Butler S, Picard S, Palinski W, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994;14:32-40.
10. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992;339: 883-887.
11. Mironova M, Virella G, Lopes-Virella MF. Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol. 1996;16:222-229.
12. Maggi E, Perani G, Falaschi F, Frattoni A, Martignoni A, Finardi G, Stefano PL, Simeone F, Paolini G, DeVecchi E, Grossi A, Bellomo G. Autoantobodies against low-density lipoproteins in patients with coronary atherosclerosis. Presse Med. 1994;23:1158-1162.
13. Raitakari OT, Pitkänen O-P, Lehtimäki T, Lahdenpera S, Iida H, Ylä-Herttuala S, Luoma J, Mattila K, Nikkari T, Taskinen M-R, Viikari JSA, Knuuti J. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. J Am Coll Cardiol. 1997;30:97-102.
14. Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arteroscler Thromb Vasc Biol. 1997;17:3159-3163.
15. Ben-Yehuda O, Witztum JL, Keaney JF, Frei B, Hankin B, Vita JA. Autoantibody titer to malondialdehyde modified low density lipoprotein correlates with the extent of coronary artery disease. Circulation. 1996; 94(suppl 1):1-638.
16. Bergmark C, Wu R, deFaire U, Lefvert AK, Swedenborg J. Patients with early onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol. 1995;15: 441-445.
17. Bellomo G, Maggi E, Poli M, Agosta FG, Bollati P, Finardi G. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes. 1995;44:60-66.
18. Maggi E, Marchesi E, Ravetta V, Martignoni A, Finardi G, Bellomo G. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypersention: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J Hypertens. 1995; 13:129-138.
19. Marchesi E, Martigoni A, Salvini M, Catalano O, Maggi E, Negro C, Traversa B, Bellomo G. Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension. J Hum Hypertens. 1996;10:577-582.
20. Uusitupa M, Niskanen L, Luoma J, Vilja P, Mercuri M, Rauramaa R, Ylä-Herttuala S. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16:1236-1242.
21. van de Vijver LPL, Steyger R, Van Poppel G, Boer JMA, Kruijssen DACM, Seidell JC, Princen HMG. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis. 1996;122:245-253.
22. Cherubini A, Mecocci P, Senin U. Autoantibodies against oxidized low-density lipoproteins in older stroke patients. J Am Geriatr Soc. 1997; 45:125. Letter.
23. Ameli S, Hultgårdh-Nilsson A, Regnström J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 1996;16:1074-1079.
24. Tunstall-Pedoe H for the WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Diseases): a major international collaboration. J Clin Epidemiol. 1988;41:105-114.
25. Stegmayr B, Asplund K. Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neumepidemiohgy. 1992;11:204-213.
26. Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest. 1998;101:1717-1725.
27. Wu R, Lefvert AK. Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clin Exp Immunol. 1995;102:174-180.
28. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
29. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein under-goes oxidative modification in vivo. Proc Natl Acad Sci USA. 1989;86:1372-1376.
30. Puurunen M, Mänttäri M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, Vaarala O, Aho K, Palosuo T. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med. 1994;154: 2605-2609.
31. Schmidley JW. Free radicals in central nervous system ischemia. Stroke. 1990;21:1086-1090.
32. Lai SM, Alter M, Friday G, Sobel E. A multifactorial analysis of risk factors for recurrence of ischemic stroke. Stroke. 1994;25:958-962.
33. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke: a population perspective. Diabetologia. 1995;38:1061-1068.
34. Princen HMG, Van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler Thromb. 1992;12:554-562.
35. Virella G, Virella I, Leman RB, Pryor MB, Lopes-Virella MF. Anti-oxidized low density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res. 1993; 23:95-101.
36. Reaven P, Parthasaraty S, Grasse BJ, Miller E, Steinberg D, Witztum J. Effects of oleate-rich and linoleate-rich diet on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest. 1993;91:668-676.